Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin

Journal of Lipid Research

Volumn 42, Issue 9, 2001, Pages 1450-1456

  Dallinga Thie, Geesje M ^a   Groenendijk, Martine ^a   Blom, Richard N H H C ^a,b   De Bruin, Tjerk W A ^a,c   De Kanta, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Caco 2; Familial combined hyperlipidemia; Gene regulation; HepG2; Transcription

Indexed keywords

APOLIPOPROTEIN C; APOLIPOPROTEIN C3; DNA; INSULIN;

ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; INSULIN METABOLISM; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CARCINOMA, HEPATOCELLULAR; COLONIC NEOPLASMS; DNA; GENE EXPRESSION REGULATION; GENE FREQUENCY; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; INSULIN; LIVER NEOPLASMS; NETHERLANDS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0035653006     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Localization of the structural gene for human apolipoprotein A-I on the long arm of human chromosome 11
2. Structure and expression of the human apolipoprotein A-IV gene
3. Apolipoprotein multigene family: Tandem organization of human apolipoprotein A-I, C-III, A-IV genes
4. Isolation and characterization of cDNA clones corresponding to two different human apo CIII alleles
5. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
6. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III
7. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprocin C-III
8. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: Implications for the regulation of the catabolism of these lipoproteins
9. Apolipoprotein C-II and C-III levels in hypertriglyceridemia
10. The low-density lipoprotein receptor-related protein: Double agent or decoy?
11. Inhinitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver
12. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptorrelated protein
13. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII CIII, and E
14. Human apolipoprotein A-I-C-III gene complex is located on chromosome 11
15. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice
16. Mechanism of hypertriglyceridemia in human apolipoprotein C-III transgenic mice
17. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11
18. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III
19. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes
20. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11
21. Evidence for a multilocus contribution to familial combined hyperlipidemia (FCHL)
22. Deoxyribonucleic acid polymorphism in the apolipoprotein AI-CIII gene cluster. Association with hypertriglyceridemia
23. DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary, heart disease
24. Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs
25. DNA polymorphisms of the apolipoprotein AI/CIII/ AIV gene cluster influence plasma cholesterol and triglyceride levels in the Mayans of the Yucatan Peninsula
26. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population
27. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promotor and 3′ untranslated region polymorphisms
28. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children
29. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
30. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipid-emia
31. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
32. Molecular biology, of the human apolipoprotein genes: Gene regulation and structure/function relationship
33. Transcriptional regulation of the genes involved in lipoprotein transport-the role of proximal promoters and long-range regulatory elements and factors in apolipoprotein gene regulation
34. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4
35. Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene
36. A simple salting out procedure for extracting DNA from human nucleated cells
37. Regulation of gene expression by insulin
38. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
39. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives
40. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests
41. Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men
42. Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic
43. Promotor elements and factors required for hepatic and intestinal transcription of the human apo C-III gene
44. The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers
45. Transcriptional regulation of human apolipoprotein genes apoB, apoCIII, and apoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3
46. Binding specificity, and modulation of the human apoCIII promoter activity by heterodimers of ligand-depetident nuclear receptors
47. Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human apoCIII gene